CONTEXT: Diabetes is an independent risk factor for heart failure (HF); however, it is not known whether tight glycemic control can reduce the occurrence of HF among diabetic patients. OBJECTIVE: The aim of the study was to investigate the race-specific association of different levels of glycosylated hemoglobin (HbA1c) with the risk of HF among patients with diabetes. DESIGN, SETTING, AND PARTICIPANTS: We prospectively investigated the race-specific association of different levels of HbA1c at baseline and during an average of 6.5 years of follow-up with incident HF risk among 17 181 African American and 12 446 white diabetic patients within the Louisiana State University Hospital System. MAIN OUTCOME MEASURE: We measured incident HF until May 31, 2012. RESULTS: During follow-up, 5089 HF incident cases were identified. The multivariable-adjusted hazard ratios of HF associated with different levels of HbA1c at baseline (<6.0% [reference group], 6.0-6.9%, 7.0-7.9%, 8.0-8.9%, 9.0-9.9%, and ≥10.0%,) were 1.00, 1.02 (95% confidence interval, 0.91-1.15), 1.21 (1.05-1.38), 1.29 (1.12-1.50), 1.37 (1.17-1.61), and 1.49 (1.31-1.69) (P trend < .001) for African American diabetic patients, and 1.00, 1.09 (0.96-1.22), 1.09 (0.95-1.26), 1.43 (1.22-1.67), 1.49 (1.25-1.77), and 1.61 (1.38-1.87) (P trend < .001) for white diabetic patients, respectively. This graded positive association was also present in diabetic patients with and without glucose-lowering agent treatment; in diabetic patients with different age, gender, and smoking status; and in incident HF defined as systolic HF (ejection fraction ≤ 40%) and HF with a preserved ejection fraction (ejection fraction > 40%). CONCLUSIONS: The current study suggests a graded positive association of HbA1c with the risk of HF among both African American and white patients with diabetes.
CONTEXT: Diabetes is an independent risk factor for heart failure (HF); however, it is not known whether tight glycemic control can reduce the occurrence of HF among diabeticpatients. OBJECTIVE: The aim of the study was to investigate the race-specific association of different levels of glycosylated hemoglobin (HbA1c) with the risk of HF among patients with diabetes. DESIGN, SETTING, AND PARTICIPANTS: We prospectively investigated the race-specific association of different levels of HbA1c at baseline and during an average of 6.5 years of follow-up with incident HF risk among 17 181 African American and 12 446 white diabeticpatients within the Louisiana State University Hospital System. MAIN OUTCOME MEASURE: We measured incident HF until May 31, 2012. RESULTS: During follow-up, 5089 HF incident cases were identified. The multivariable-adjusted hazard ratios of HF associated with different levels of HbA1c at baseline (<6.0% [reference group], 6.0-6.9%, 7.0-7.9%, 8.0-8.9%, 9.0-9.9%, and ≥10.0%,) were 1.00, 1.02 (95% confidence interval, 0.91-1.15), 1.21 (1.05-1.38), 1.29 (1.12-1.50), 1.37 (1.17-1.61), and 1.49 (1.31-1.69) (P trend < .001) for African American diabeticpatients, and 1.00, 1.09 (0.96-1.22), 1.09 (0.95-1.26), 1.43 (1.22-1.67), 1.49 (1.25-1.77), and 1.61 (1.38-1.87) (P trend < .001) for white diabeticpatients, respectively. This graded positive association was also present in diabeticpatients with and without glucose-lowering agent treatment; in diabeticpatients with different age, gender, and smoking status; and in incident HF defined as systolic HF (ejection fraction ≤ 40%) and HF with a preserved ejection fraction (ejection fraction > 40%). CONCLUSIONS: The current study suggests a graded positive association of HbA1c with the risk of HF among both African American and whitepatients with diabetes.
Authors: Sebhat Erqou; Chee-Tin Christine Lee; Matthew Suffoletto; Justin B Echouffo-Tcheugui; Rudolf A de Boer; Joost P van Melle; Amanda I Adler Journal: Eur J Heart Fail Date: 2012-10-25 Impact factor: 15.534
Authors: Elizabeth Selvin; Spyridon Marinopoulos; Gail Berkenblit; Tejal Rami; Frederick L Brancati; Neil R Powe; Sherita Hill Golden Journal: Ann Intern Med Date: 2004-09-21 Impact factor: 25.391
Authors: A Pazin-Filho; A Kottgen; A G Bertoni; S D Russell; E Selvin; W D Rosamond; J Coresh Journal: Diabetologia Date: 2008-10-01 Impact factor: 10.122
Authors: Wenhui Zhao; Peter T Katzmarzyk; Ronald Horswell; Yujie Wang; Jolene Johnson; William T Cefalu; Donna H Ryan; Gang Hu Journal: J Clin Endocrinol Metab Date: 2013-05-28 Impact factor: 5.958
Authors: William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang Journal: N Engl J Med Date: 2008-12-17 Impact factor: 91.245
Authors: Elizabeth Selvin; Mariana Lazo; Yuan Chen; Lu Shen; Jonathan Rubin; John W McEvoy; Ron C Hoogeveen; A Richey Sharrett; Christie M Ballantyne; Josef Coresh Journal: Circulation Date: 2014-08-22 Impact factor: 29.690
Authors: Wenhui Zhao; Peter T Katzmarzyk; Ronald Horswell; Yujie Wang; Weiqin Li; Jolene Johnson; Steven B Heymsfield; William T Cefalu; Donna H Ryan; Gang Hu Journal: Circulation Date: 2014-11-05 Impact factor: 29.690
Authors: Nan Li; Peter T Katzmarzyk; Ronald Horswell; Yonggang Zhang; Weiqin Li; Wenhui Zhao; Yujie Wang; Jolene Johnson; Gang Hu Journal: Diabetes Care Date: 2014-09-23 Impact factor: 19.112
Authors: Siu-Hin Wan; Isabel Torres-Courchoud; Paul M McKie; Joshua P Slusser; Margaret M Redfield; John C Burnett; David O Hodge; Horng H Chen Journal: JACC Basic Transl Sci Date: 2019-12-23